These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8859894)

  • 21. Monoclonal antibodies against the human metalloprotease EC 3.4.24.15 label neurofibrillary tangles in Alzheimer's disease brain.
    Conn KJ; Pietropaolo M; Ju ST; Abraham CR
    J Neurochem; 1996 May; 66(5):2011-8. PubMed ID: 8780030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyloid-β Modulates Both AβPP and Tau Phosphorylation.
    Oliveira JM; Henriques AG; Martins F; Rebelo S; da Cruz e Silva OA
    J Alzheimers Dis; 2015; 45(2):495-507. PubMed ID: 25589714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of mint-1, mint-2, and APP overexpression in okadaic acid-treated neurons.
    Yoon S; Choi J; Haam J; Choe H; Kim D
    Neuroreport; 2007 Dec; 18(18):1879-83. PubMed ID: 18007179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microinjection of synthetic amyloid beta-protein in monkey cerebral cortex fails to produce acute neurotoxicity.
    Podlisny MB; Stephenson DT; Frosch MP; Tolan DR; Lieberburg I; Clemens JA; Selkoe DJ
    Am J Pathol; 1993 Jan; 142(1):17-24. PubMed ID: 8424453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD40 ligation mediates plaque-associated tau phosphorylation in beta-amyloid overproducing mice.
    Laporte V; Ait-Ghezala G; Volmar CH; Ganey C; Ganey N; Wood M; Mullan M
    Brain Res; 2008 Sep; 1231():132-42. PubMed ID: 18606155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of beta (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy.
    Baker HF; Ridley RM; Duchen LW; Crow TJ; Bruton CJ
    Mol Neurobiol; 1994 Feb; 8(1):25-39. PubMed ID: 8086126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The monoclonal antibody Alz-50, used to reveal cytoskeletal changes in Alzheimer's disease, also reacts with a large subpopulation of somatostatin neurons in the normal human hypothalamus and adjoining areas.
    van de Nes JA; Sluiter AA; Pool CW; Kamphorst W; Ravid R; Swaab DF
    Brain Res; 1994 Aug; 655(1-2):97-109. PubMed ID: 7812796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A possible fetal antigen of Mr 70,000 in neurofibrillary tangles.
    Morishima-Kawashima M; Arai T; Ogawara M; Takio K; Titani K; Saitoh T; Kosik KS; Ihara Y
    Brain Res; 1991 Jul; 554(1-2):316-20. PubMed ID: 1933313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease.
    Perry G; Cras P; Siedlak SL; Tabaton M; Kawai M
    Am J Pathol; 1992 Feb; 140(2):283-90. PubMed ID: 1739122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pathology of the neuronal cytoskeleton in Alzheimer's disease.
    Brion JP
    Biochim Biophys Acta; 1992 Nov; 1160(1):134-42. PubMed ID: 1384716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Similarities between beta amyloid peptides 1-40 and 40-1: effects on aggregation, toxicity in vitro, and injection in young and aged rats.
    Giordano T; Pan JB; Monteggia LM; Holzman TF; Snyder SW; Krafft G; Ghanbari H; Kowall NW
    Exp Neurol; 1994 Feb; 125(2):175-82. PubMed ID: 8313936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments.
    Su JH; Cummings BJ; Cotman CW
    Brain Res; 1996 Nov; 739(1-2):79-87. PubMed ID: 8955927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P.
    Kowall NW; Beal MF; Busciglio J; Duffy LK; Yankner BA
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7247-51. PubMed ID: 1714596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic utility of quantitating neurofilament-immunoreactive Alzheimer's disease lesions.
    de la Monte SM; Wands JR
    J Histochem Cytochem; 1994 Dec; 42(12):1625-34. PubMed ID: 7983363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The monoclonal antibody, Alz 50, recognizes tau proteins in Alzheimer's disease brain.
    Nukina N; Kosik KS; Selkoe DJ
    Neurosci Lett; 1988 May; 87(3):240-6. PubMed ID: 3132653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The neurotoxicity of amyloid beta protein in aged primates.
    McKee AC; Kowall NW; Schumacher JS; Beal MF
    Amyloid; 1998 Mar; 5(1):1-9. PubMed ID: 9546999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthetic amyloid beta-protein fails to produce specific neurotoxicity in monkey cerebral cortex.
    Podlisny MB; Stephenson DT; Frosch MP; Lieberburg I; Clemens JA; Selkoe DJ
    Neurobiol Aging; 1992; 13(5):561-7. PubMed ID: 1281288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenesis of Alzheimer-related neuritic plaques: AT8 immunoreactive dystrophic neurites precede argyrophilic neurites in plaques of the entorhinal region, hippocampal formation, and amygdala.
    Yilmazer-Hanke DM
    Clin Neuropathol; 1998; 17(4):194-8. PubMed ID: 9707333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stage-correlated distribution of type 1 and 2 dystrophic neurites in cortical and hippocampal plaques in Alzheimer's disease.
    Thal DR; Härtig W; Schober R
    J Hirnforsch; 1998; 39(2):175-81. PubMed ID: 10022341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer's disease. The density of amygdalar neuritic plaques is associated with the severity of neurofibrillary pathology and the degree of beta-amyloid protein deposition in the cerebral cortex.
    Yilmazer-Hanke DM
    Acta Anat (Basel); 1998; 162(1):46-55. PubMed ID: 9789108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.